The New England Journal Of Medicine
-
{
- All
- News
-
Prostate Cancer Treatment May Double Dementia Risk: Study
Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as those whose hormone levels are not tampered with, researchers including one of Indian origin have found.
-
Prostate Cancer Treatment May Double Dementia Risk: Study
Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as those whose hormone levels are not tampered with, researchers including one of Indian origin have found.
-
New Treatment Holds Best Option for Stroke Patient
For its ability to reduce the incidence of disability, a procedure called Endovascular Therapy (ET) could be the best option for many stroke sufferers, says a study co-authored by an Indian-origin doctor.
-
Prostate Cancer Treatment May Double Dementia Risk: Study
Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as those whose hormone levels are not tampered with, researchers including one of Indian origin have found.
-
Prostate Cancer Treatment May Double Dementia Risk: Study
Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as those whose hormone levels are not tampered with, researchers including one of Indian origin have found.
-
New Treatment Holds Best Option for Stroke Patient
For its ability to reduce the incidence of disability, a procedure called Endovascular Therapy (ET) could be the best option for many stroke sufferers, says a study co-authored by an Indian-origin doctor.
